Romo, Michelle .

HRN: 23-77-09  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/14/2026
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
04/14/2026
04/20/2026
IVT
225mg
Q6H
PCAP-C
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Pneumonia    Compliance to guidelines: